维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="GLATTING G"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Radiationexposure of patients under going whole-body dual-modality 18F-FDG PET/CT Examinations显示文摘	Brix G Lechel G Glatting G		0，，04：	1
2	Dosimetric fundamentals of endovascular brachytherapy using 188Re to prevent restenosis after angioplasty显示文摘	Kotzerke J Rentschler M Glatting G	1998	Nuklearmedizin1998，37，：	1
3	choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy显示文摘	Reske SN Blumstein NM Glatting G	2008	Eur J Nucl Med Mol Imaging2008，35，1：	1
4	Prospective e- valuation of the clinical value of planar bone scans, SPECT, and F-labeled NaF PET in newly diagnosed lung cancer显示文摘	Schimneister H Glatting G Hetzel J	2001	J Nucl Med2001，42，12：	1
5	Quantification of 18 F-FDG uptake in non-small cell lung cancer:a feasible prognostic marker?显示文摘	Buck AK Glatting G Reske SN	2004	J Nucl Med2004，45，8：	1
6	Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma显示文摘	Reske S N Grillenberger K G Glatting G	1997	J Nucl Med1997，38，：	1
7	Radiation exposure of patients undergoing whole-body dual-modality lSF-FDG PET/CT examinations显示文摘	Brix G Lechel U Glatting G	2005	J Nucl Med2005，46，4：	1
8	Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma显示文摘	Beske SN Grillenberger KG Glatting G	1997	J Nucl Med1997，38，9：	1
9	2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation显示文摘	Stolffuss JC Glatting G Friess H	1995	Radiology1995，195，2：	1
10	Quantification of ^18F FDG uptake in non-small cell lung cancer: a feasible prognostic marker? 显示文摘	Buck A K Glatting G Reske S N	2004	J Nucl Med2004，45，8：	1
11	Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer显示文摘	Schirrmeister H Arslandemir C Glatting G	2004	Eur J Nucl Med Mol Imaging2004，31，7：	1
12	Quantification of 18F FDG uptake in non-small cell lung cancer:a feasible prognostic marker?显示文摘	Buck AK Glatting G Reske SN	2004	J Nucl Med2004，45，：	1
13	2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer:value of quantitative image interpretation显示文摘	STOLLFUSS J C GLATTING G FRIESS H	1995	Radiology1995，195，2：	1
14	Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer显示文摘	Schirrmeister H Arslandemir C Glatting G	2004	Eur J Nucl Med Mol Imaging2004，31，：	1
15	Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma显示文摘	Reske S N Grillenberger K G Glatting G	1997	J Nucl Medl1997，38，9：	1
16	Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer显示文摘	Arslandemir C Glatting G	2004	Eur J Nucl Med Mol Imaging2004，31，3：	1
17	2 - (fluorine-18) - fluoro 2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation 显示文摘	Glatting G Friess H	1995	Radiology1995，195，：	1
18	Blurring of vessels in spiral CTangiography: effects of collimation width, pitch, viewing plane, and windowing in maximumintensity projection显示文摘	Diederchs CG Keating DP Glatting G	1996	J Compute Assist Tomogr1996，20，5：	1
19	Overcopression of glucose transporter 1 and increased FDG uptake in pancreatic Carcinoma显示文摘	Reske SN Grillenberger KG Glatting G	1997	J Nucl Med1997，38，：	1
20	Radiation exposure of patients undergoing whole-body dual-modality ~SF-FDG PET/CT examina- tions显示文摘	Brix G Lechel U Glatting G	2005	J Nucl Med2005，46，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示